BioSpace News Archive

CartiHeal, developer of Agili-C™, a proprietary implant for the treatment of cartilage lesions in arthritic and non-arthritic joints, announced today the first implantation of the Agili-C™ implant, as part of Investigational Device Exemption (IDE) clinical study by Joseph M. Berman, MD at Arlington Orthopedics Associates (AOA), Arlington, TX.

Orphazyme A/S (ticker: ORPHA.CO), a biopharmaceutical company dedicated to developing treatments for patients living with rare diseases, recently announced the completion of enrollment to its phase 3 trial of arimoclomol in amyotrophic lateral sclerosis (ALS)

The first phase of a plan to establish a Diagnostics Center of Excellence at MRIGlobal’s headquarters in Kansas City has been completed and is now fully operational.

DiA Imaging Analysis Ltd. (DiA), a leading provider of artificial intelligence (AI)-powered ultrasound analysis solutions, announced a partnership with Edan Instruments Inc., a leading medical products and services company.

Cirqle Biomedical announced that it has secured $1.8M for pre-clinical development of a novel non-hormonal contraceptive technology.

Turn-key solution for the sustainable advancement and growth of clinical research sites

EBR Systems, Inc., developer of the world’s only wireless cardiac pacing system for heart failure, today announced it has closed $30M in new funding to complete enrollment of its pivotal SOLVE CRT clinical trial and to prepare for commercialization of the WiSE Cardiac Resynchronization Therapy (CRT) System.

Angel MedFlight Worldwide Air Ambulance will be a featured VMware customer partner at the VMworld 2019 conference, August 25-29 in San Francisco, California.

Ivy Rehab Physical Therapy (Ivy) continues to rapidly expand its footprint, with six new clinics being added to the Ivy Rehab Network of physical and occupational therapy practices in recent weeks.

Smiths Medical, a leading global medical device manufacturer, announced today it has partnered with Medline Industries for distribution of the Portex® acapella® choice vibratory PEP therapy device.